LifeStance Health Group Inc. Common Stock Q3 2025 Earnings Recap

LFST Q3 2025 November 6, 2025

Get alerts when LFST reports next quarter

LifeStance Health reported a standout third quarter with 17% organic visit growth and record-high adjusted EBITDA margins, reinforcing its robust operational model and strategic positioning in the mental health sector.

Earnings Per Share Beat

$0.00 vs $-0.01 est.

+127.7% surprise

Revenue Miss

363809000 vs 378513880 est.

-3.9% surprise

Market Reaction

1-Day +29.94%

5-Day +34.51%

30-Day +33.26%

See LFST alongside your other holdings

Add to your portfolio — free

Key Takeaways

Revenue reached $364 million, reflecting a 16% year-over-year increase driven by strong visit volumes.
Achieved adjusted EBITDA of $40 million, marking an 11% margin, the highest since going public in 2021.
Added a record 288 organic clinicians, bringing the total to nearly 8,000, enhancing patient access and service quality.
Partnership with Calm expands referral capabilities, enhancing patient pathways to care.
Full-year guidance for adjusted EBITDA raised, indicating strong confidence in ongoing growth momentum.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit LFST on AllInvestView.

Previous Q2 2025